These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7196632

  • 1. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M, Lutherer S, Terhorst B.
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A, Morvay J, Vécsei B.
    Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract] [Full Text] [Related]

  • 7. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J, Catane R.
    J Med; 1984 Apr 26; 15(1):35-43. PubMed ID: 6593404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A, Shukla SK, Welvaart K, Murphy GP.
    Cancer Chemother Rep; 1975 Apr 26; 59(1):219-23. PubMed ID: 1093669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T, Kubo T, Akasaka T, Funyu T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1988 Aug 26; 34(8):1493-502. PubMed ID: 3057833
    [Abstract] [Full Text] [Related]

  • 18. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K.
    Arch Chir Neerl; 1975 Aug 26; 27(3):193-8. PubMed ID: 55103
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A, Lunglmayr G.
    Wien Med Wochenschr; 1983 Aug 26; 133(7):179-81. PubMed ID: 6868629
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.